ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2664

Color Doppler Ultrasound for the Diagnosis of Giant Cell Arteritis in Montreal: A Canadian Single Center Experience

Jean-Paul Makhzoum1, Meriem Belhocine 1, Michelle Goulet 1, Maxime Rheaume 1, Tara Starnino 2, Stephanie Ducharme-Benard 2, Guillaume Febrer 3, Yves Troyanov 4, Nathalie Routhier 5, Rosalie-Selene Meunier 5, Isabelle Chagnon 5, Michel Laurier 5, Maggy Helou 5, Nathalie Morency 6 and Anne-Marie Mansour 1, 1Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 2Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, Canada, 3Vascular Surgery, Department of Surgery, Hopital du Sacre-Coeur de Montreal, Montreal, Canada, 4Division of Rheumatology, Department of Medicine, Hôpital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 5Internal Medicine, Department of Medicine, Hopital du Sacre-Coeur de Montreal, Montreal, Canada, 6Division of Rheumatology, Department of Medicine, Montreal, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diagnostic imaging and temporal arteritis, Doppler ultrasound, giant cell arteritis, large vessel vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant Cell Arteritis (GCA) remains challenging to diagnose as false negative temporal artery biopsy (TAB) can occur. Color doppler ultrasonography (CDUS) of the temporal, axillary and carotid arteries is useful when GCA is suspected. A wide range of sensitivities and specificities of CDUS are reported, with better results when performed by a trained sonographer using high resolution equipment. The new GCA probability score (GCAPS) is intended to risk-stratify patients with suspected GCA into those with high probability versus low probability of GCA. This study aimed to 1) compare CDUS results against TAB with final diagnosis of the specialist as the reference standard; 2) determine how GCAPS performs in relation to the final diagnosis.

Methods: A retrospective chart review was performed for all patients with suspected GCA who had a CDUS from July 2017 to May 2019, at Hopital du Sacre-Coeur de Montreal (University of Montreal). All exams were performed by the same ultrasonographer with the Zonare Z One Ultra Ultrasound SystemTM using a linear array probe (L14-5Mhz). Data collected included patient characteristics, clinical presentation, physical examination, bloodwork, initial clinical suspicion of GCA (low or moderate/high) and CDUS results of the temporal, carotid and axillary arteries. TAB results and final diagnosis as determined by the treating physician were documented. GCAPS was retrospectively calculated if all the required items were available.

Results: A total of 56 patients had a CDUS examination during the specified time period; amongst them, 31 patients had a TAB. GCA was the final diagnosis in 20 patients, as determined by the treating specialist. Sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) were 95.0%, 100%, 100%, 97.3% for CDUS; and 81.3%, 100%, 100%, 83.3% for TAB, respectively. There were no false positive CDUS in patients without GCA. Only 1 patient with GCA had a negative CDUS while the TAB was positive. A false negative TAB was observed in 3 patients with GCA, all of which had a positive CDUS. In those 3 patients with negative TAB and positive CDUS, one had extra-cranial large-vessel vasculitis on PET/CT, the second had abnormal temporal arteries on physical examination (tenderness and pulselessness) and the third had classic cranial symptoms of GCA with thrombocytosis and elevated inflammatory markers. False negative rate of CDUS was 5% as opposed to 18.7% for TAB.

GCAPS score of < 9.5 points was found in 1 patient with GCA and 21 patients without GCA. At a cut-off value of 9.5 points, Se, Sp, PPV and NPV for the GCAPS were 95.0%, 65.6%, 69.3% and 95.5% respectively. In our cohort, GCA was the final diagnosis for all patients with a GCAPS ≥ 13 points.

Conclusion: CDUS of the temporal, carotid and axillary arteries showed a high Se and Sp and helped to identify TAB negative patients with GCA. We validated that the GCAPS is a useful clinical tool in our patient population; a score < 9.5 points makes the diagnosis of GCA unlikely.


Disclosure: J. Makhzoum, None; M. Belhocine, None; M. Goulet, None; M. Rheaume, None; T. Starnino, None; S. Ducharme-Benard, None; G. Febrer, None; Y. Troyanov, None; N. Routhier, None; R. Meunier, None; I. Chagnon, None; M. Laurier, None; M. Helou, None; N. Morency, None; A. Mansour, None.

To cite this abstract in AMA style:

Makhzoum J, Belhocine M, Goulet M, Rheaume M, Starnino T, Ducharme-Benard S, Febrer G, Troyanov Y, Routhier N, Meunier R, Chagnon I, Laurier M, Helou M, Morency N, Mansour A. Color Doppler Ultrasound for the Diagnosis of Giant Cell Arteritis in Montreal: A Canadian Single Center Experience [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/color-doppler-ultrasound-for-the-diagnosis-of-giant-cell-arteritis-in-montreal-a-canadian-single-center-experience/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/color-doppler-ultrasound-for-the-diagnosis-of-giant-cell-arteritis-in-montreal-a-canadian-single-center-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology